CompletedNCT02299440
Ketamine for Short-Term Suicidal Thoughts
About this title
Effects of Ketamine in the Acute Phase of Suicidal Ideation
Read the official source — NCT02299440Medication studyAges 18+FranceSuicide prevention
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- Clermont-Ferrand and 8 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateStarted: April 2015
- Recruitment status
- Completed
- Enrollment listed in the registry
- 156
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- France
- Age range
- Over 18 Years
- Official registry ID
- NCT02299440
- Official title
Show the full official title
Evaluation of the Effects of Ketamine in the Acute Phase of Suicidal Ideation: a Multicenter Randomized Double-blind Trial
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Clermont-Ferrand · Lille · Montpellier
3 more locations
- Nîmes
- Paris
- Saint-Cyr-sur-Loire
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Centre Hospitalier Universitaire de Nīmes.
Did this study involve medication?
Yes. The study involved medication, including 1st perfusion of ketamine, 1st perfusion of saline, 2nd perfusion of ketamine and 2nd perfusion of saline.
Who was this study for?
Listed age limits: from 18 years.
